{"i": ["glycopyrronium bromide"], "o": []}
{"i": [], "o": []}
{"i": ["Glycopyrronium bromide ( NVA237 )"], "o": []}
{"i": ["glycopyrronium bromide"], "o": ["efficacy and safety"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["mean trough FEV1"]}
{"i": [], "o": []}
{"i": ["glycopyrronium bromide", "placebo"], "o": ["bronchodilation", "mean trough FEV1"]}
{"i": [], "o": ["Pharmacodynamic steady - state"]}
{"i": [], "o": ["mean trough FEV1"]}
{"i": [], "o": []}
{"i": ["placebo"], "o": ["FEV1", "FEV1 AUC0"]}
{"i": ["placebo"], "o": ["trough FEV1"]}
{"i": ["Glycopyrronium bromide"], "o": ["safe and well tolerated"]}
{"i": ["Glycopyrronium bromide"], "o": []}
{"i": [], "o": []}
{"i": ["glycopyrronium bromide"], "o": []}
{"i": ["Glycopyrronium bromide ( NVA237 )"], "o": []}
{"i": ["glycopyrronium bromide"], "o": ["efficacy and safety"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["mean trough FEV1"]}
{"i": [], "o": []}
{"i": ["glycopyrronium bromide", "placebo"], "o": ["bronchodilation", "mean trough FEV1"]}
{"i": [], "o": ["Pharmacodynamic steady - state"]}
{"i": [], "o": ["mean trough FEV1"]}
{"i": [], "o": []}
{"i": ["placebo"], "o": ["FEV1", "FEV1 AUC0"]}
{"i": ["placebo"], "o": ["trough FEV1"]}
{"i": ["Glycopyrronium bromide"], "o": ["safe and well tolerated"]}
{"i": ["Glycopyrronium bromide"], "o": []}
{"i": [], "o": []}
{"i": ["glycopyrronium bromide"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["muscarinic antagonists ( LAMAs )"], "o": []}
{"i": ["LAMA"], "o": ["mortality risk", "exercise tolerance and health status", "disease progression"]}
{"i": [], "o": ["duration of action , rapid onset of action", "safety and tolerability profile"]}
{"i": ["glycopyrronium bromide .", "NVA237"], "o": []}
{"i": [], "o": []}
{"i": ["Glycopyrronium bromide"], "o": []}
{"i": [], "o": ["forced expiratory volume in 1 second ( FEV1"]}
{"i": ["tiotropium", "glycopyrronium bromide"], "o": ["bronchodilatory efficacy and duration of action"]}
{"i": ["glycopyrronium bromide"], "o": ["bronchodilation and responder rates", "tolerability profiles"]}
{"i": ["glycopyrronium bromide"], "o": []}
{"i": ["glycopyrronium bromide"], "o": ["tolerated"]}
{"i": [], "o": []}
{"i": ["glycopyrronium bromide"], "o": ["efficacy and safety"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["ipratropium bromide"], "o": ["bronchodilator FEV1 to forced vital capacity ( FVC ) ratio"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["salbutamol / albuterol"], "o": []}
{"i": ["inhaled corticosteroids ( ICS ) and long - acting \u03b22 - agonists ( LABA )"], "o": []}
{"i": ["short - acting anticholinergics", "LABAs", "parenteral or oral corticosteroids", "short - acting \u03b22 - agonists other than rescue medication", "long - acting anticholinergics", "intramuscular depot corticosteroids", "fixed combinations of inhaled short - acting anticholinergics and short - acting \u03b22 - agonists", "xanthines"], "o": []}
{"i": [], "o": []}
{"i": ["mizolastin", "non - selective beta - blockers", "systemic anticholinergics", "Ketotifen", "leukotriene antagonists", "Nedocromil", "cromoglycate"], "o": []}
{"i": ["inactivated influenza vaccination , pneumococcal vaccination or any other inactivated vaccine"], "o": []}
{"i": [], "o": []}
{"i": ["glycopyrronium bromide", "placebo"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["placebo"], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["FEV1 and FVC"]}
{"i": [], "o": []}
{"i": [], "o": ["trough FEV1"]}
{"i": [], "o": ["FEV1 area under the curve", "FEV1 AUC0 - 4h , FEV1 AUC0 - 12h , FEV1 AUC12 - 24h , FEV1", "peak FEV1"]}
{"i": [], "o": []}
{"i": [], "o": ["adverse events ( AEs", "pregnancies , assessing vital signs , and electrocardiogram ( ECG )"]}
{"i": [], "o": ["Haematology , blood chemistry and urinalysis parameters"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["glycopyrronium bromide", "placebo"], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["trough FEV1"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["FEV1 response"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["dose response"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["glycopyrronium bromide", "placebo"], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["bronchodilation", "FEV1"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["QTc interval"]}
{"i": [], "o": ["BID \u2013 OD difference in trough response"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["duration of COPD"]}
{"i": [], "o": ["Mean post - bronchodilator FEV1"]}
{"i": ["Glycopyrronium bromide", "Placebo"], "o": []}
{"i": ["Glycopyrronium bromide"], "o": []}
{"i": [], "o": ["bronchodilation"]}
{"i": ["glycopyrronium bromide", "placebo"], "o": ["mean trough FEV1"]}
{"i": ["glycopyrronium bromide", "placebo"], "o": ["FEV1"]}
{"i": [], "o": ["mean trough FEV1"]}
{"i": ["glycopyrronium bromide", "placebo", "Glycopyrronium bromide"], "o": ["FEV 1"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["placebo"], "o": []}
{"i": [], "o": ["FEV1 AUC0 - 4h , FEV1 AUC0 - 12h , and FEV1 AUC12 - 24h"]}
{"i": [], "o": ["FEV1 AUC0 - 4h"]}
{"i": [], "o": ["FEV1 AUC0 - 12h"]}
{"i": [], "o": ["FEV1 AUC12 - 24h"]}
{"i": [], "o": ["FEV1"]}
{"i": [], "o": []}
{"i": [], "o": ["spirometric outcomes"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["OD profiles"]}
{"i": ["OD"], "o": []}
{"i": [], "o": []}
{"i": ["glycopyrronium bromide"], "o": []}
{"i": ["placebo"], "o": ["FEV1"]}
{"i": [], "o": []}
{"i": ["glycopyrronium bromide", "placebo"], "o": ["AEs"]}
{"i": ["glycopyrronium bromide", "placebo"], "o": ["nasopharyngitis and headache", "nasopharyngitis", "dyspnoea and diarrhoea", "COPD ( worsening )"]}
{"i": [], "o": ["AE frequency"]}
{"i": ["glycopyrronium bromide", "Glycopyrronium bromide"], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["serious AEs"]}
{"i": [], "o": ["AEs", "COPD worsening"]}
{"i": ["glycopyrronium bromide", "placebo"], "o": ["Cardiac disorder"]}
{"i": ["glycopyrronium bromide"], "o": ["death"]}
{"i": ["glycopyrronium bromide"], "o": []}
{"i": [], "o": ["COPD worsening ."]}
{"i": ["glycopyrronium bromide"], "o": ["mild headache"]}
{"i": ["glycopyrronium bromide"], "o": ["systolic pressure", "haematology or clinical chemistry parameter values", "mean minimum and maximum values", "pulse rate", "vital signs", "diastolic blood pressure"]}
{"i": [], "o": ["ECG parameters"]}
{"i": ["glycopyrronium bromide"], "o": []}
{"i": [], "o": ["AUC0 - 24h FEV1"]}
{"i": ["placebo"], "o": ["FEV1", "FEV1 AUC0"]}
{"i": [], "o": []}
{"i": [], "o": ["night - time symptoms", "day - time symptoms"]}
{"i": ["placebo"], "o": ["FEV1", "trough FEV1"]}
{"i": ["glycopyrronium bromide"], "o": []}
{"i": ["tiotropium", "aclidinium"], "o": ["normalized FEV1", "spirometric profiles"]}
{"i": ["BID dosing", "OD dosing"], "o": []}
{"i": [], "o": ["healthcare utilization costs"]}
{"i": [], "o": ["airway calibre"]}
{"i": [], "o": []}
{"i": [], "o": ["adherence"]}
{"i": [], "o": []}
{"i": ["glycopyrronium bromide"], "o": []}
{"i": ["glycopyrronium bromide"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["FEV1"]}
{"i": [], "o": ["FEV1", "St . George ' s Respiratory Questionnaire ( SGRQ ) and Transition Dyspnoea Index"]}
{"i": ["Glycopyrronium bromide", "placebo"], "o": ["FEV1"]}
{"i": ["placebo"], "o": ["moderate / severe exacerbations", "dyspnoea , SGRQ and rescue medication use"]}
{"i": ["Glycopyrronium bromide"], "o": ["tolerated"]}
{"i": ["placebo -", "glycopyrronium bromide"], "o": ["AEs"]}
{"i": ["glycopyrronium bromide"], "o": ["overall safety profile", "tolerated"]}
{"i": ["glycopyrronium bromide"], "o": []}
{"i": [], "o": ["FEV1 AUC0"]}
{"i": [], "o": ["patient adherence"]}
{"i": ["glycopyrronium bromide"], "o": ["efficacy and safety"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
